S-013420

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2014
01220092014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
OBJECTIVES New antimicrobials are essential to prevent gonorrhoea becoming an untreatable infection. Herein, the in vitro… (More)
  • table 1
  • figure 1
Is this relevant?
2014
2014
The pharmacodynamic profile of modithromycin (EDP-420, EP-013420, S-013420), a novel bicyclolide, was evaluated in a neutropenic… (More)
Is this relevant?
2014
2014
Ketolides are erythromycin A derivatives with a keto group replacing the cladinose sugar and an aryl-alkyl group attached to the… (More)
  • figure 1
  • table 1
Is this relevant?
2010
2010
S-013420 (EDP-420) is a novel bicyclolide (bridged bicyclic macrolide) antibacterial currently under development for the… (More)
Is this relevant?
2010
2010
OBJECTIVES The in vitro activity of S-013420, a novel bicyclolide, was investigated. METHODS All test strains for this study… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
2010
2010
The pharmacokinetic (PK)/pharmacodynamic (PD) parameters and the antibacterial activity of S-013420, a novel bicyclolide, against… (More)
Is this relevant?
2009
2009
EDP-420 (also known as EP-013420, or S-013420) is a first-in-class bridged bicyclolide currently in clinical development for the… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 4
Is this relevant?
2009
2009
EDP-420 (EP-013420, S-013420) is a first-in-class bicyclolide (bridged bicyclic macrolide) currently in clinical development for… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?